MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.jclinane.2021.110600

Медицинская библиотека · Journal of clinical anesthesia · 2021

Post-cesarean gabapentin is not associated with lower opioid consumption or pain scores in women on chronic buprenorphine therapy: A 10-year retrospective cohort study.

Ende Holly B, Bauchat Jeanette R, Sorabella Laura L, Raymond Britany L, Feng Xiaoke, Shotwell Matthew S, Richardson Michael G

СтатьяПеревод в очереди

Аннотация

STUDY

OBJECTIVE

To determine if postoperative gabapentin administration is associated with decreased opioid consumption or pain scores following cesarean delivery in women on chronic buprenorphine.

DESIGN

Retrospective cohort study.

SETTING

Postoperative recovery area and postpartum inpatient unit.

PATIENTS: 214 women undergoing cesarean delivery while on chronic buprenorphine at a single institution between 2007 and 2017.

INTERVENTIONS: Gabapentin treatment for post-cesarean analgesia.

MEASUREMENTS: The primary outcome was opioid consumption in morphine milligram equivalents, comparing patients who received ≥1 dose of gabapentin within 24 h of cesarean delivery to those who did not. Secondary outcomes included opioid consumption 24-48 and 48-72 h post-cesarean and postoperative numerical rating scale pain scores.

MAIN

RESULTS

Of 214 included patients, 64 (30%) received gabapentin while 150 (70%) did not. Gabapentin patients were more likely than controls to have received neuraxial fentanyl (30% vs. 14%, p = 0.01) and transversus abdominis plane block (6% vs. 1%, p = 0.05) and overall received higher doses of ketorolac and acetaminophen. Control patients were more likely to have received neuraxial morphine (78% vs. 90%, p = 0.04) and received higher doses of ibuprofen. In unadjusted analysis, there was no significant difference in morphine milligram equivalent consumption 0-24 h postoperatively between gabapentin (55 mg [IQR 26,84]) and control (53 mg [IQR 28,75]) groups (p = 0.38). After controlling for potential confounders, there remained no significant effect of gabapentin administration (overall effect p = 0.99). Opioid consumption and pain scores were also not significantly different at any other time points.

CONCLUSIONS

In parturients receiving chronic buprenorphine, inclusion of gabapentin in a multimodal analgesic regimen was not associated with lower opioid consumption or pain scores during the first 72 h after cesarean delivery. Prospective randomized studies are needed to confirm these findings.

Для цитирования: Ende Holly B, Bauchat Jeanette R, Sorabella Laura L, Raymond Britany L, Feng Xiaoke, Shotwell Matthew S, Richardson Michael G. Post-cesarean gabapentin is not associated with lower opioid consumption or pain scores in women on chronic buprenorphine therapy: A 10-year retrospective cohort study.. Journal of clinical anesthesia. 2021. DOI: 10.1016/j.jclinane.2021.110600.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.